Validation of the Friedewald Formula in Patients with Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Currently, the Friedewald formula (FF) is the main method for evaluating low-density lipoprotein cholesterol (LDL-c). Recently, many limitations have emerged regarding its use, including patients with triglyceride levels ≥400 mg/dL, diabetes mellitus, and kidney or hepatic chronic diseases. We analyzed the use of the FF in patients with metabolic syndrome. We selected patients with known metabolic syndrome that fulfilled the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report and excluded patients with triglyceride levels ≥400 mg/dL and chronic liver and/or kidney disease. Using direct assays, we measured total cholesterol, high-density lipoprotein cholesterol, triglycerides, and LDL-c. Then, LDL-c was estimated using the FF and compared with the LDL-c by direct assay. The sample size was 135 patients. Using the FF, the mean LDL-c value was 124.4±42.1 mg/dL; it was 125.1±38.5 mg/dL by direct assay. The correlation coefficient between these two methods was 0.89, with statistical significance (P value<0.001). There were no significant differences between the patients with triglyceride levels >150 mg/dL (P=0.618). In conclusion, FF is a good method for estimating LDL-c in patients with metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, comparisons between calculated and direct LDL-C show good agreement.81”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [81]
Experimental — accuracy not yet measuredIn the citing paper
“In general, comparisons between calculated and direct LDL-C show good agreement. 81”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Sposito, A. C., Caramelli, B., Fonseca, F. A. H., Bertolami, M. C., Afiune Neto, A., Souza, A. D., Lottenberg, A. M. P., Chacra, A. P., Faludi, A. A., Loures-Vale, A. A., et al. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000700002 · Cited by 558
Self-citationNauck, M., Warnick, G. R., & Rifai, N. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.236 · Cited by 442
Kathiresan, S., Otvos, J. D., Sullivan, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W. F., D’Agostino, R. B., Vasan, R. S., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.567107 · Cited by 318
I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica
(2005) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2005000700001 · Cited by 299
Research works printed but not linked: 6
- 2005, Arquivos Brasileiros de Cardiologia, 84, 3
- 2007, Arquivos Brasileiros de Cardiologia, 88
- 2005, Anadolu Kardiyoloji Dergisi, 5, 13
- 2008, Revista Brasileira de Análises Clínicas, 40, 279
- 2005, Journal of the Medical Association of Thailand, 88, S274
- 2008, Archives of Iranian Medicine, 11, 318
Cited by
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Del Bo', C., Bernardi, S., Cherubini, A., Porrini, M., Gargari, G., Hidalgo-Liberona, N., González-Domínguez, R., Zamora-Ros, R., Peron, G., Marino, M., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.014 · Cited by 133
Aleali, A. M., Amani, R., Shahbazian, H. B., Namjooyan, F., Latifi, S. M., & Cheraghian, B. (2019) · Phytotherapy Research · doi:10.1002/ptr.6351 · Cited by 105
Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation
Li, F., Armet, A. M., Korpela, K., Liu, J., Quevedo, R. M., Asnicar, F., Seethaler, B., Rusnak, T., Cole, J. L., Zhang, Z., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.034 · Cited by 88
Metadata
- Authors
- Knopfholz, J., Disserol, C. C. D., Pierin, A. J., Schirr, F. L., Streisky, L., Takito, L. L., Massucheto Ledesma, P., Faria-Neto, J. R., Olandoski, M., da Cunha, C. L. P., & Bandeira, A. M.
- Affiliations
- Pontifícia Universidade Católica do Paraná (BR)
- Pontifícia Universidade Católica do Paraná, Rua Imaculada Conceição, Prado Velho, 1155 Curitiba, PR, Brazil
- Corresponding author
- Disserol, Caio César Diniz
- Venue
- Cholesterol
- Publisher
- Wiley
- Published
- 2014-02-06
- Volume
- 2014
- Pages
- 1-5
- ISSN
- 2090-1283 (ISSN-L)
- 2090-1291
- PMC
- PMC3941209
- OpenAlex
- W2035400847
- Cited by
- 196
- References
- 28
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 20 · 2023: 21 · 2022: 26 · 2021: 25 · 2020: 26 · 2019: 14 · 2018: 10 · 2017: 9 · 2016: 8 · 2015: 6 · 2014: 1
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cholesterol (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Pontifícia Universidade Católica do Paraná
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- Friedewald formula, LDL cholesterol estimation, metabolic syndrome, triglycerides, method validation, hypertriglyceridemia, Adult Treatment Panel III criteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Validation of the Friedewald Formula in Patients with Metabolic Syndrome. https://app.cochat.ai/papers/10.1155/2014/261878
- The paper
- Knopfholz, J., Disserol, C. C. D., Pierin, A. J., Schirr, F. L., Streisky, L., Takito, L. L., Massucheto Ledesma, P., Faria-Neto, J. R., Olandoski, M., da Cunha, C. L. P., & Bandeira, A. M. (2014). Validation of the Friedewald Formula in Patients with Metabolic Syndrome. Cholesterol. https://doi.org/10.1155/2014/261878
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.